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B cell development is a tightly regulated process
dependent on sequential rearrangements of immu-
noglobulin loci that encode the antigen receptor. To
elucidate the role of microRNAs (miRNAs) in the
orchestration of B cell development, we ablated all
miRNAs at the earliest stage of B cell development
by conditionally targeting the enzymes critical for
RNAi in early B cell precursors. Absence of any
one of these enzymes led to a block at the pro- to
pre-B cell transition due to increased apoptosis
and a failure of pre-B cells to proliferate. Expression
of a Bcl2 transgene allowed for partial rescue of
B cell development, however, the majority of the
rescued B cells had low surface immunoglobulin
expression with evidence of ongoing light chain
editing. Our analysis revealed that miRNAs are crit-
ical for the regulation of the PTEN-AKT-FOXO1
pathway that in turn controls Rag expression during
B cell development.INTRODUCTION
MicroRNAs (miRNAs) are small (22 nucleotides) endogenous
non-coding RNAs (ncRNAs) that regulate gene expression by a
process known as RNAi. RNAi is an evolutionary conserved
mechanism regulating many physiological processes suchCell Repor
This is an open access article under the CC BY-Nas development, cell differentiation, proliferation, and survival
(Castel and Martienssen, 2013; Pauli et al., 2011; Wilson and
Doudna, 2013).
miRNA genes are transcribed by RNA polymerase II into dou-
ble-stranded hairpin primary miRNAs (pri-miRNAs). The micro-
processor composed of the ribonuclease (RNase) III Drosha
and the double stranded RNA binding protein DiGeorge critical
region 8 (DGCR8) cut the pri-miRNAs into shorter stem-loop pre-
cursor miRNAs (pre-miRNAs). Pre-miRNAs are exported from
the nucleus into the cytoplasm, where they are further cleaved
by the RNase III Dicer into 20–23 nucleotides miRNAs duplexes.
The mature miRNA, is then incorporated into the RNA-induced
silencing complex (RISC) and guides the complex to the 30UTR
of target mRNAs, leading to degradation and/or translational in-
hibition of the targetmRNA (Krol et al., 2010;Wilson andDoudna,
2013; Winter et al., 2009). In vertebrates, hundreds of miRNA
genes have been identified and more are predicted by compu-
tational analysis with each miRNA capable of regulating gene
expression of numerous target genes (Lim et al., 2003, 2005).
In addition to the canonical miRNAs, which depend onDrosha,
DGCR8, and Dicer for their biogenesis, other ncRNAs have been
described that differ in their requirement for Dicer or the micro-
processor complex (Okamura and Lai, 2008). Among these
ncRNAs are miRNAs that are independent of Dicer, endogenous
transposons, small nucleolar RNAs, endogenous small inter-
fering RNAs, mirtrons produced by splicing, and long ncRNAs
(Babiarz et al., 2008; Ender et al., 2008; Ruby et al., 2007;
Seong et al., 2014). The function, processing, and regulation of
many of these classes of ncRNAs in mammals remain to be fully
elucidated.ts 17, 2271–2285, November 22, 2016 ª 2016 The Author(s). 2271
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
B lymphocytes develop in the bone marrow (BM) through a
tightly regulated process resulting in expression of a functional
and unique B cell receptor (BCR) on the cell surface. The BCR
is composed of a membrane bound antibody together with the
signal transducing immunoglobulin (Ig) a and b subunits. Diver-
sity of BCRs is achieved through somatic V(D)J rearrangements
at the Ig heavy (IgH) and light (IgL) chain loci, mediated by the
recombination activating genes (RAG) 1 and 2. Following IgH
and IgL rearrangements at the pro-B and pre-B cell stage,
respectively, immature B cells expressing a the newly minted
BCR on their surface leave the bone marrow and enter circula-
tion (Rajewsky, 1996). Despite being extensively studied, our
understanding of B cell development remains fragmentary (Bus-
slinger, 2004; Peled et al., 2008; Stavnezer et al., 2008).
Recently, there has been growing interest in the possible role
of small ncRNAs in B cell development and function. The differ-
ential expression of miRNAs throughout B cell development sug-
gests that these ncRNAs contribute to stage-specific regulation
of the intricate transcriptional program during B cell develop-
ment (Kuchen et al., 2010; Spierings et al., 2011). Indeed, condi-
tional ablation of Dicer at different stages of B cell development
reveals a critical role of Dicer-dependent ncRNAs in pre-B cells,
follicular, and germinal center B cells (Belver et al., 2010; Koralov
et al., 2008; Xu et al., 2012). These studies, as well as several in-
vestigations into the role of individual miRNAs throughout B cell
development (Benhamou et al., 2016; Chen et al., 2004; Fragoso
et al., 2012; Gonzalez-Martin et al., 2016; Koralov et al., 2008; Lai
et al., 2016; Rao et al., 2010; Ventura et al., 2008; Xiao et al.,
2007; Zhou et al., 2007), suggest that miRNAs are important
for choreographing the expression of the various transcription
factors and other key components controlling the different
stages of B cell development and function. Several miRNAs
that have been shown to be important in B cells are deregulated
in B cell lymphomas (Di Lisio et al., 2012; He et al., 2005; Mu
et al., 2009; Xiao et al., 2008) suggesting a role of miRNAs in
B cell lymphomagenesis both in human and mouse. Although
these studies demonstrate a critical role for miRNAs in the regu-
lation of B cell development and function, they do not provide a
complete picture of the role of miRNAs in B cell differentiation,
because they do not take into account the fact that different
miRNAs can act in concert to regulate a given signaling pathway.
A more global approach is therefore necessary.
In the present study, we compare the phenotypes of mice in
which Dicer, Drosha, or Dgcr8 are conditionally ablated in the
B cell lineage. Phenotypic changes observed upon conditional
ablation of Dicer may be mediated not just by the Dicer-depen-
dent miRNAs, but other Dicer-dependent ncRNAs. Analysis of
B lymphocytes lacking components of the microprocessor
complex (Drosha or DGCR8) allow us to unequivocally identify
the impact of miRNA loss. Conditional deletion of either Dicer,
Drosha, or Dgcr8 led to an early block in B cell development
due to increased cell death and decreased proliferation at the
pre-B stage. Rescue of B cell development by overexpression
of the anti-apoptotic factor Bcl2 revealed that in the absence
of these enzymes critical to miRNA biogenesis, B lineage cells
in the periphery expressed low surface levels of Ig heavy chains
without expressing light chains. Furthermore, because the
phenotype of the Drosha- and DGCR8-deficient B cells mirrored2272 Cell Reports 17, 2271–2285, November 22, 2016that of Dicer null B cells, we conclude the regulation of gene
expression bymiRNAwas central to this phenotype. As a conse-
quence of miRNA loss the phosphatidylinositol 3-kinase (PI3K)/
AKT pathway was downregulated in themutant cells through up-
regulation of phosphatase and tensin homolog (PTEN), leading
to inappropriate RAG1 and RAG2 expression and continuous
light chain editing. Our data suggest a critical role for miRNAs
in the maintenance of a mature phenotype in peripheral B cells.
RESULTS
Drosha, DGCR8, and Dicer Deficiency Results in a
Similar Block of B Cell Development at an Early Stage
We have previously demonstrated that Dicer1fl/fl Mb1-cre mice
present a severe defect in B cell development (Koralov et al.,
2008). To investigate whether the impaired B cell development
was due to the lack of miRNAs or to absence of other ncRNAs,
we crossed mice harboring conditional alleles for Dgcr8 (Wang
et al., 2007) or Drosha (Chong et al., 2008) withMb1-cre animals
(Hobeika et al., 2006). In thesemice,Dgcr8 orDrosha are deleted
at the earliest stage of B cell development. In Dgcr8fl/fl Mb1-cre
mice, pro-B cells (B220+IgMc-kit+) accumulated whereas only
few pre-B cells (B220+IgMCD25+) were present. Immature
(B220IntIgM+) and recirculating (B220HiIgM+) B cells were largely
absent in the bone marrow of these mice (Figures 1A and S1A).
Consistent with the complementary role of DGCR8 and Drosha
in the microprocessor complex, the block in B cell development
in Droshafl/fl Mb1-cre mice closely resembled that observed in
Dgcr8fl/fl Mb1-cre animals (Figures S1A and S1B). This block at
the pro-B to pre-B transition in Dgcr8fl/fl Mb1-cre and Droshafl/fl
Mb1-cre mice recapitulated the B cell developmental defect
observed in Dicer1fl/fl Mb1-cre mice (Koralov et al., 2008). This
suggested that ncRNAs processed by DGCR8, Drosha, and
Dicer, most probably miRNAs, are critical for the transition
from the pro- to the pre-B cell stage.
Annexin V staining revealed a striking increase in apoptotic
pre-B, but not pro-B cells, in Dgcr8fl/fl Mb1-cre and Droshafl/fl
Mb1-cre mice compared to controls (Figures 1B and S2A). We
have previously described upregulation of Bim upon deletion
of Dicer in pre-B cells (Koralov et al., 2008), and B lymphocytes
deficient for the miR-1792 family members also exhibited
higher level of this pro-apoptotic Bcl2 family member (Ventura
et al., 2008). Consistent with the global loss of miRNAs in these
cells, pro-B and pre-B cells from the bone marrow of Dgcr8fl/fl
Mb1-cre (Figure 1C) or Droshafl/flMb1-cre (Figure S2B) mice ex-
pressed high levels of intracellular Bim protein. Taken together,
the increased apoptosis and elevated Bim levels observed in
Drosha-, DGCR8-, and Dicer-deficient pre-B cells underscore
the critical role of miRNAs in pre-B cell survival.
Our previous analysis of Dicer-deficient B cells had identified
the tumor suppressor PTEN as being upregulated in these cells
(Koralov et al., 2008). Accordingly, intracellular levels of PTEN
were higher in DGCR8- and Drosha-deficient pro-B and pre-B
cells compared to control cells (Figures 1D and S2C). PTEN is
a negative regulator of the PI3K pathway known to play an
important role in cell-cycle regulation (Sun et al., 1999) and
B cell development (Werner et al., 2010). Large pre-B cells
(FSChiB220+CD25+ckitIgM) are characterized by the rapid
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Figure 1. Block in Early B Cell Development in Absence of Microprocessor Complex
(A) Representative FACS plots of bone marrow from Dgcr8fl/fl Mb1-cre and Dgcr8fl/+ Mb1-cre control animals. Events are gated on total lymphocytes. Plots
showing pro-B cells (B220+c-kit+) and pre-B cells (B220+CD25+) cells are gated on B220+ IgM B lymphocyte progenitor cells (n > 5 mice).
(B) Representative Annexin V staining of pro-B and pre-B cells gated as in (A) from mice of the indicated genotypes (n > 5 mice).
(C and D) Representative histograms for intracellular Bim (C) and PTEN (D) staining on pro-B and pre-B cells gated as in (A) from Dgcr8fl/flMb1-cre (solid line) or
control (shaded) mice (n > 5 mice).
(E) DNA content analysis assayed using DRAQ5 incorporation from small or large pre-B cells (gated on B220+IgMCD25 then gated on size) from BM of animals
with B cell-specific deficiency in DGCR8 (n > 5 mice).
(F) Representative FACS analysis of spleen from Dgcr8fl/fl mb1-cre and control animals. Events are gated on total lymphocytes. (nR 5 mice).
See also Figures S1 and S2.
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proliferation that takes place prior to IgL chain recombination at
the small pre-B cell stage. To examine the role of miRNAs in the
regulation of cell-cycle progression during B cell development,
we examined DNA content in small and large pre-B cells. We
found that the fraction of large pre-B cells was severely reduced
and that these cells appeared to be arrested in cell-cycle pro-
gression at the G0/G1 stage in the absence of Dicer, Drosha,
or DGCR8, as determined by staining of the cells with the DNA
intercalating dye DRAQ5 (Figures 1E and S2D). Taken together,
our data suggest that the reduction of the pre-B cell compart-
ment and the developmental B cell block observed in the
absence of Dicer, Drosha, or DGCR8 could be attributed to
both increased cell death and decreased proliferation, as a
consequence of the lack of miRNAs.
Consistent with the severe developmental block in the bone
marrow, we observed a paucity of splenic B cells in absence of
DGCR8, Drosha, and Dicer. Spleens of Dgcr8fl/fl Mb1-cre and
Droshafl/fl Mb1-cre mice were largely devoid of B cells as shown
by the drastic decrease in B220+ CD19+ B cell percentage and
cell number compared to controls (Figures 1F, S1C, and S1D)
similar to the lack of peripheral B cells that we have previously
observed in Dicer1fl/fl Mb1-cre animals (Koralov et al., 2008).
A Bcl2 Transgene Is Capable of Partially Rescuing
Drosha- and DGCR8-Deficient B Cells
To rescue B cell development inDgcr8fl/flMb1-cre andDroshafl/fl
Mb1-cre mice, we took advantage of a Bcl2 transgene (Tg)
restricted to the B cell lineage (EmBcl2Tg) (Strasser et al., 1991),
as we have previously demonstrated that Bcl2 overexpression
partially rescues B cell development in the absence of Dicer
(Koralov et al., 2008). While B cell development was still compro-
mised, we observed a reduced accumulation of pro-B cells
accompanied by a slight increase in pre-B cells in Dgcr8fl/fl
Mb1-cre EmBcl2Tg mice compared to the Dgcr8fl/fl Mb1-cre
animals (Figures 2A and 2B). The percentage of immature and
recirculating cells was significantly higher in Dgcr8fl/fl Mb1-cre
EmBcl2Tg mice compared to Dgcr8fl/fl Mb1-cre mice (Figure 2B).
The developmental block was similarly attenuated by the
expression of Bcl2 in Drosha-deficient mice (Figure 2C) as in
Dicer-deficient mice (Koralov et al., 2008).
Despite the B cell intrinsic loss of miRNAs in the absence of
either of the three enzymes required for RNAi, there was a
distinct population (12%) of B220+CD19+ B cells in the spleens
of Dgcr8fl/fl Mb1-cre EmBcl2Tg and Droshafl/fl Mb1-cre EmBcl2Tg
mice analogous to what we had previously observed in Dicer1fl/fl
Mb1-cre EmBcl2Tg mice (Figures 3A–3C and S3A). Thus, ectopic
expression of the pro-survival EmBcl2Tg resulted in partial rescue
of B cell development and accumulation of peripheral B cells in
the absence of either DGCR8, Drosha, or Dicer.
To evaluate whether B cells lacking DGCR8, Drosha, or Dicer
and rescued with the EmBcl2Tg exhibited an equal loss of mature
miRNAs, we examined levels of members of the miR-1792
family of miRNAs, previously shown to be important for B cell
development (Koralov et al., 2005; Ventura et al., 2008), as
well miR-142-5p and miR-181a, which are highly expressed in
murine B cells (Chen et al., 2004; Landgraf et al., 2007). These
miRNAs were decreased at least 10-fold in B220+ CD19+ B cells
sorted from Dgcr8fl/fl Mb1-cre EmBcl2Tg mice compared to con-2274 Cell Reports 17, 2271–2285, November 22, 2016trol B cells (Figure 3D and data not shown). A similar decrease
in miRNA expression was observed in B cells from Droshafl/fl
Mb1-cre EmBcl2Tg mice (Figure S3B). The traces of miRNAs
detected in knockout (KO) B cells by real-time PCR may either
represent the remaining average levels of mature miRNAs in
the sorted cells or may come from the few cells in the total B
cell pool that have escaped Mb1-cre-mediated deletion of the
targeted alleles.
Most Bcl2 Rescued miRNA-Deficient B Cells Display
Low Surface Ig Expression
The partial rescue of RNAi-deficient B cells upon expression of
transgenic Bcl2 allowed us to further explore the role of Dicer,
Drosha, and DGCR8 in mature splenic B lymphocytes. Staining
these cells for a variety of surface markers, we observed that
up to 75% of the rescued DGCR8 KO, Drosha KO, and Dicer
KO B cells expressed levels of surface IgM that were markedly
lower than the levels on control cells (Figures 4A, S4A and
S4B). We designated the cells with low expression of surface
IgM, ‘‘Iglow’’ cells and cells expressing surface IgM levels similar
to Bcl2 control cells, ‘‘Ighigh’’ cells. The Iglow RNAi-deficient
B lymphocytes otherwise expressed the typical B cell markers
that we examined (including CD19, B220, CD23, and CD21)
(data not shown). They did not appear to be plasma cells based
on fluorescence-activated cell sorting (FACS) analysis and
morphology (CD138 and FSC parameters were examined; data
not shown). We then considered whether the Iglow DGCR8 KO,
Drosha KO, and Dicer KO B cells may have a defect in the pro-
cessing of the m heavy chain that requires alternative splicing be-
tween the c4 and m1 exons for expression of membrane-bound
antibody (Alt et al., 1980; Early et al., 1980; Rogers et al., 1980).
However, real-time PCR analysis of mRNA levels for the two
alternative forms of the m heavy chain revealed that Iglow B cells
from all three mutants showed a comparable (albeit lower) ratio
of secreted to membrane splice variants compared to B cells
from control mice (Figure S4C). This suggests that altered
splicing of IgmmRNAwas not responsible for the Iglow phenotype
in the absence of RNAi.
In an effort to further characterize Iglow B cells, we examined
surface expression and intracellular protein level of Igm heavy
chains as well as Igk and Igl light chains in these cells. FACS
analysis revealed that despite low surface levels of Igm, most
Iglow cells stained positive for intracellular Igm, with most cells
having comparable levels to those observed in B cells from litter-
mate controls (Figure 4B). Surface staining for Ig light chains re-
vealed that Iglow cells from Dgcr8fl/fl Mb1-cre EmBcl2Tg animals
lack any detectable surface expression of Igk or Igl, while Ighigh
cells have an unusually high fraction of l+ B cells (Figure 4C). The
percentage of l+ B cells was 2-fold higher in Bcl2 control mice
compared to wild-type littermates (data not shown), consistent
with previous observations (Lang et al., 1997), but the Ighigh
miRNA-deficient B cell compartment contained as many as
10%–25% l+ B cells. Intracellular analysis of Igk and Igl light
chains demonstrated that indeed Iglow cells were entirely devoid
of detectable Ig light chain proteins (Figure 4D). These observa-
tions were recapitulated in B cells from Droshafl/fl Mb1-cre
EmBcl2Tg and Dicer1fl/fl Mb1-cre EmBcl2Tg mice (data not
shown). Because Iglow cells were expressing heavy chainwithout
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(A) Surface IgM levels of B220+CD19+ B cells from the spleen of Dgcr8fl/fl Mb1-cre EmBcl2Tg (black histogram) and Dgcr8fl/+ EmBcl2Tg mice (gray histogram).
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(C) Representative FACS analysis of Igk and Igl on the surface of B220+CD19+ splenic B cells of Dgcr8fl/+Mb1-cre EmBcl2Tg mice and on the Ighigh or Iglow cells
(gated based on surface Igm levels) from the same Dgcr8fl/fl Mb1-cre EmBcl2Tg animals (n > 15).
(D) Intracellular staining for Igk (top) or Igl (bottom) in B220+CD19+ splenic B cells as in (B) (n > 15).
(E) Expression of the surrogate light chain component l5 and VpreBmRNAwas determined by real-time PCR in Ighigh and Iglow B220+CD19+CD25- B cells sorted
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normalized to hprt are relative to pre-B cells from control bone marrow (mean ± SD indicated; more than three independent experiments. *p % 0.05).
(F) miRNAs levels were assayed by real-time PCR in Ighigh or Iglow B220+CD19+CD25- B cells sorted based on surface IgM expression from spleen of mice
deficient or not for DGCR8 and expressing EmBcl2Tg. Data is normalized to U6 and represented relative to control cells (mean ± SD indicated; more than three
independent experiments. *p% 0.05).
See also Figure S4.
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light chain at their surface, we hypothesized that Igmmay be co-
expressed with the pre-BCR components l5 and VpreB. Anal-
ysis of gene expression by real-time PCR revealed that the genes
encoding these proteins, whose expression is normally limited
to the progenitor B cells in the bone marrow, were expressed
in Iglow but not Ighigh B cells from Dgcr8fl/fl Mb1-cre EmBcl2Tg,
Droshafl/fl Mb1-cre EmBcl2Tg, and Dicer1fl/fl Mb1-cre EmBcl2Tg
mice (Figure 4E and data not shown). As expected, B cells
from control animals did not have any detectable expression of
the pre-BCR components.
The presence of two seemingly distinct populations of B cells,
Ighigh and Iglow, among the Bcl2 Tg-rescued miRNA-deficient
B cells raised the question of how complete the deletion of Dicer,
Drosha, or DGCR8 was in these lymphocytes. We sorted Iglow
and Ighigh cells from Dgcr8fl/fl Mb1-cre EmBcl2Tg, Droshafl/fl
Mb1-cre EmBcl2Tg, and Dicer1fl/fl Mb1-cre EmBcl2Tg mice as
well as cells from control animals and performed real-time
PCR analysis of Dgcr8, Drosha, and Dicer mRNA. Drosha,
Dgcr8, or Dicer transcripts were barely detectable in both Iglow
and Ighigh cells from the corresponding mice (Figure S4D).
In addition, cells fromDgcr8fl/flmb1-cre EmBcl2Tgmice, irrespec-
tive of whether Iglow or Ighigh, expressed low levels of, if any,
miRNAs. The average levels of miRNAs that we examined did
appear higher in Ighigh compared to Iglow cells, consistent with
the possibility that the Ighigh cells represented precursors of Iglow
lymphocytes (Figure 4F). Similar results were obtained for cells
purified from dicer1fl/fl Mb1-cre EmBcl2Tg and Droshafl/fl Mb1-
cre EmBcl2Tg mice (data not shown).
Light Chain Editing in Peripheral Rescued B Cells
Lacking miRNAs
We sorted Ighigh and Iglow B cells from the spleens of Dgcr8fl/fl
Mb1-cre EmBcl2Tg mice as well as B cells from control mice
expressing EmBcl2Tg and investigated whether the absence of
Ig light chains in Iglow cells was due to impaired Ig light chain
gene rearrangement. These rearrangements generally start at
the Igk locus with Jk1 and Jk2 preferentially rearranged (Nishi
et al., 1985; Vela et al., 2008). Sequencing of the Vk-Jk joints in
Iglow cells revealed skewing toward the more distal Jk4 and
Jk5 usage in Igk joints (Figure S5A) and predominantly non-pro-
ductive out-of-frame joints (Figure S5B) suggesting secondary
light chain rearrangements in these cells. Analysis of the different
cell populations by real-time PCR of genomic DNA revealed
increased levels of rearrangement between a Vk gene element
and the recombining sequence (RS) or between the intronic RS
(IRS) and RS in splenic B cells from Dgcr8fl/fl Mb1-cre EmBcl2Tg
Iglow cells (Figure 5A). Recombinations involving RS remove or
invert the k light chain constant region, inactivating expression
of the Igk allele and allowing recombination to occur on the sec-
ond Igk allele or alternatively on one of the Igl alleles (Vela et al.,
2008). We found that Iglow cells, and to a lesser extent Ighigh cells,
had increased Vl-Jl1 rearrangements compared to control cells
(Figure 5A). These findings suggested that there was increased
light chain editing occurring inDgcr8fl/flMb1-cre EmBcl2Tg B cells
as well as in Dicer1fl/flMb1-cre EmBcl2Tg and Droshafl/fl Mb1-cre
EmBcl2Tg B cells (Figure S5C and data not shown). Light chain
editing is known to occur either in pre-B cells that fail to acquire
an in-frame/functional rearrangement on one of the Ig light chain2278 Cell Reports 17, 2271–2285, November 22, 2016loci, or in pre-B cells that acquire a self-reactive BCR. We exam-
ined the Igk locus in Dgcr8fl/fl Mb1-cre EmBcl2Tg pre-B cells to
investigate if editing in the absence of DGCR8 was occurring
at the pre-B cell stage. We found that in the RNAi-deficient
pre-B cells the Igk locus was in the germline configuration at
least as often as in control pre-B cells (i.e., did not show evidence
of ongoing rearrangement). Furthermore, DGCR8-deficient pre-
B cells had similar levels of Vk-RS recombination and Vl-Jl1
rearrangement to control pre-B cells (Figure 5B). These data
suggested that secondary light chain rearrangement was not
occurring at higher levels in KO pre-B cells within the BM
compared to control pre-B cells, but rather that the increase in
editing that we observed in Iglow cells occurred after the devel-
oping B cells left the BM compartment.
We studied colocalization of gH2AX, the phosphorylated form
of H2AX, as a marker for DNA double-stranded breaks, with the
Igk loci by immuno-DNA fluorescence in situ hybridization (FISH)
in splenic Dicer1fl/fl Mb1-cre EmBcl2Tg Iglow cells. We used two
probes that hybridize 50 and 30 of the Igk locus respectively
together with an antibody against gH2AX. We found that the
percentage of cells with gH2AX colocalized with Igk was signif-
icantly higher in Iglow cells compared to control or Ighigh cells,
suggesting that Igk rearrangement was occurring in Iglow cells
more frequently than in the other two populations. The levels of
gH2AX at the Igk locus of Iglow cells was only 2-fold lower
than that observed in pre-B cells from control mice (Figures 5C
and 5D; Table S1). Taken together, our data suggest that light
chain editing is ongoing in Iglow splenic miRNA-deficient B cells.
Increased Rag and FOXO1 Expression in miRNA-
Deficient Splenic B Cells
Ig gene recombination and editing is mediated by RAG1 and
RAG2, both normally expressed in pro-B and pre-B cells, with
no detectable transcription in peripheral B cells (Han et al.,
1997; Hikida et al., 1996). However, in RNAi-deficient Iglow
B cells, Rag1 and Rag2 mRNA was readily detectable, consis-
tent with ongoing Ig light chain rearrangement. Expression of
these genes in Iglow cells, albeit at significantly lower levels
compared to pre-B cells, suggests that Ig light chain rearrange-
ment in Iglow cells is mediated by expression of RAG1 and RAG2.
As expected, control splenic B cells did not express detectable
levels of either Rag1 or Rag2. Rag1 and Rag2 transcripts were
also undetectable in the RNA from Dgcr8fl/fl Mb1-cre EmBcl2Tg
Ighigh cells (Figure 6A)
While Iglow cells lack expression of progenitor markers such as
c-kit, CD43, and CD25, we wanted to exclude the possibility that
the observed expression of Rag1/2 in these cells was due to
contaminating pre-B cells. For this purpose, we treated Dgcr8fl/fl
Mb1-cre EmBcl2Tg and EmBcl2Tg control mice with anti-IL7Ra
antibody for 2 weeks (Figure S6A) to arrest B cell development
and thus prevent bone marrow output of pre-B cells (Sudo
et al., 1993). Iglow cells sorted from the treated animals ex-
pressed both Rag1 and Rag2 at levels similar to non-treated
mice (Figure S6B). These results demonstrate that RNAi-defi-
cient Iglow cells are not bone marrow-derived progenitor cells.
Furthermore, the data also suggest that expression of Rag1/2
in the Iglow B cells is independent of IL-7. To further validate
these results, we used an independent approach where we
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Figure 5. Ongoing Light Chain Editing in Iglow Cells
(A) Light chain rearrangement was assessed by real-time PCR of Vk-RS, IRS-RS, and Vl-Jl1 joints in the gDNA from DGCR8-deficient (DCGR8 KO Bcl2) or
sufficient (control Bcl2) splenic B220+CD19+CD25 B cells sorted according to surface IgM levels into Ighigh and Iglow cells. Data is normalized to l5 and levels in
control cells set as 100%. T cells from control mice are used as a negative control. Values shown are mean ± SD of more than three independent experiments.
(B) Germline status of the k alleles and ongoing light chain rearrangement at the IgL loci was evaluated in control or DGCR8-deficient pre-B cells sorted from the
bonemarrow ofDgcr8fl/flMb1-cre EmBcl2Tg (DGCR8 KOBcl2) andDgcr8fl/+Mb1-cre EmBcl2Tg (control Bcl2) animals. Data is normalized to l5 and plotted relative
to control EmBcl2Tg pre-B cells. Values shown are mean ± SD of more than three independent experiments.
(C) Immuno-DNA FISH of the frequency of gH2AX association with Igk loci in control EmBcl2+ pre-B, control B or Ighigh, and Iglow B220+CD19+CD25 B cells
sorted according to surface IgM expression from spleens of Dicer1fl/fl Mb1-cre EmBcl2Tg (Dicer KO Bcl2) cells. Data are displayed as a combination of two in-
dependent experimental sets (nR 133 cells for each genotype; see Table S1 for individual datasets).
(D) Top: confocal microscopy sections of two Igk loci with a gH2AX focus on one locus. 50Igk in green, 30Igk in red, and gH2AX in white. Scale bar, 1 mm. Bottom:
schematic of the positions of probes.
See also Figure S5.induced in vivo deletion of Dicer in B cells by injecting three times
poly(I:C) into Dicerfl/fl mice (Murchison et al., 2005) carrying the
type 1 interferon-inducible Mx1-cre Tg (K€uhn et al., 1995). Oneweek after the last injection, B cell development in the bone-
marrow was abrogated, and there were virtually no transitional
(AA4.1+ B220+) B cells in the spleen (Figure S6C). We foundCell Reports 17, 2271–2285, November 22, 2016 2279
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Figure 6. Downregulation of AKT Activity
Leads to Increase FOXO1 and Rag1/2
Levels in RNAi-Deficient B Cells
(A) Transcript levels of Rag1 and Rag2 in
B220+CD19+CD25 Ighigh or Iglow splenic B cells
deficient for DGCR8 (DGCR8 KO Bcl2) or in con-
trol B cells expressing Bcl2 Tg (Control Bcl2). Data
is normalized to hprt and represented as relative to
EmBcl2Tg control pre-B cells. Values shown are
mean ± SD of more than three independent ex-
periments. *p% 0.05.
(B) Western blot analysis of FOXO1 in purified
splenic B220+CD19+CD25 B cells from Dicer1fl/fl
Mb1-cre EmBcl2Tg or control EmBcl2Tg mice. His-
tone H3 was used as a loading control. The
black vertical lines indicate that unrelated samples
were run on the same gel in between the different
samples shown.
(C) Intracellular levels of total AKT (top) and
phospho-AKT (Ser473) (bottom) in B220+ B cells
from the spleen ofDgcr8fl/flMb1-cre EmBcl2Tg (red
line) or control (blue line) mice. Background levels
are shown by the shaded histogram. AKT activa-
tion as defined by the ratio of the median fluores-
cence intensity (MFI) of pAKT to total AKT MFI
(mean ± SD; n = 6 mice, ***p value < 0.001).
(D) Histogramof intracellular PTEN in B220+CD19+
B cells from the spleen of Dgcr8fl/fl Mb1-cre
EmBcl2Tg (red line) or control (blue line) mice (n > 6
mice).
(E) Transcript levels of Rag1 and Rag2 in wild-type
mature (B220+CD19+AA4.1) B cells cultured for
the indicated time with the PI3K inhibitors
(Ly294002 and Wortmannin), the AKT inhibitor
(AKT inhibitor VIII), the ERK inhibitor (PD98959) or
DMSO. Data is normalized to hprt and represented
relative to EmBcl2Tg control pre-B cells. Values
shown are mean ± SD of three independent
experiments.
See also Figure S6.that B cells from the spleen of Dicer ablated mice expressed
readily detectable levels of Rag1/2 mRNA (Figure S6D).
Rag1 and Rag2 were expressed in Dicer- Drosha-, and
DGCR8-deficient EmBcl2 rescued Iglow cells suggesting that
miRNAs regulate Rag1 and Rag2 mRNA expression. Transcrip-
tion of Rag1 and Rag2 during light chain rearrangement and re-
ceptor editing in pre-B and immature B cells have been shown to
be regulated by forkhead box O (FOXO)1 downstream of the
PI3K/AKT pathway (Amin and Schlissel, 2008; Herzog et al.,
2008). We investigated if this pathway was also involved in the
BCR editing observed in miRNA-deficient Iglow cells. While
FOXO1 protein is expressed at very low levels in control splenic
B cells, it was readily detectable in pre-B and bone marrow
immature B cells sorted from control animals, consistent with
the ongoing light chain Ig rearrangement in these cells. Levels
of total FOXO1 were highly elevated in sorted splenic B cells
from Dicerfl/fl Mb1-cre EmBcl2Tg mice as determined by western2280 Cell Reports 17, 2271–2285, November 22, 2016blot analysis (Figure 6B). Levels of Foxo1
mRNAs were similar in DGCR8-deficient
or proficient B cells suggesting a post-transcriptional regulation of Foxo1 (Figure S6E). Cellular localiza-
tion and levels of FOXO1 protein are regulated by AKT-mediated
FOXO1 phosphorylation. Phosphorylated FOXO1 is exported
from the nucleus into the cytoplasmwhere it is degraded (Tzivion
et al., 2011). We found increased FOXO1 levels in miRNA-defi-
cient B cells suggesting that phosphorylation of FOXO1 and sub-
sequent degradation is compromised in absence of miRNAs.
Intracellular staining revealed increased levels of total AKT in
splenic B cells of Dgcr8fl/fl Mb1-cre EmBcl2Tg and Dicer1fl/fl
Mb1-cre EmBcl2Tg mice when compared to AKT levels from con-
trol B cells (Figures 6C, top, and data not shown). AKT activation
is dependent on its phosphorylation at Th308 and S437 residues
(Sarbassov et al., 2005; Stephens et al., 1998). A strong
decrease in S473 phosphorylation of AKT was observed in
RNAi-deficient B cells (Figure 6C, bottom). We used the ratio
of median fluorescence intensity (MFI) of phosphorylated AKT
to the MFI of total AKT to assess the activation of the AKT
A C
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Figure 7. Complete B Cell Rescue with EmBcl2 and IgHEL Transgene in Absence of Dicer
(A) Number of B220+CD19+ B cells in the spleen of the indicated mice. Data from the mice expressing IgHEL by itself and marked with an asterisk has been
previously described (Koralov et al., 2008) (mean ± SD, nR 3, p values are shown when significant).
(B) Representative FACS plots of B220 and IgM staining in the spleen of mice of the indicated genotype. Number in graph indicates percentage of cells in the gate.
Number above graph indicates the B cell number in the spleen of the indicated mice (nR 3).
(C) Levels of miR-181 inDicerfl/flMb1-cre EmBcl2Tg IgHELTg and control splenic B cells as determined by real-time PCR. Data is normalized to U6 and represented
relative to control cells.pathway. DGCR8-deficient and Dicer-deficient B cells had a sig-
nificant decrease in AKT activation (Figure 6C, right, and data not
shown) consistent with the increased levels of FOXO1 observed
in these cells. pTh308 levels were also decreased in B cells lack-
ing miRNAs (Figure S6F). Phosphorylation of AKT is downstream
of PI3K activation and can be antagonized by PTEN. Consistent
with previous reports that PTEN is directly regulated by several B
cell intrinsic miRNAs (Benhamou et al., 2016; Gonzalez-Martin
et al., 2016; Lai et al., 2016; Xiao et al., 2008) we found that
PTEN levels were strongly elevated in miRNA-deficient B cells
compared to B lymphocytes from control animals (Figure 6D).
We sorted wild-type splenic mature B cells (CD19+B220+
AA4.1) and treated them in vitro with the PI3K inhibitors
Ly294002 and Wortmannin as well as an AKT-specific inhibitor,
AKT inhibitor VIII. Inhibition of PI3K in these mature B cells re-
sulted in induction of Rag1 and Rag2 expression after 5 hr incu-
bation and became more notable at 24 hr. Incubation with
the AKT inhibitor also led to Rag1 and Rag2 expression, albeit
to a lesser extent. Cells treated with DMSO as a vehicle controlor an ERK inhibitor (PD98959), as well as non-treated mature
B cells did not expressRag1/2 (Figure 6E). These results suggest
that the PI3K/AKT pathway regulates Rag1/2 expression in
mature B cells. Taken together, our findings demonstrate that
miRNAs regulate Rag1/2 expression through control of PTEN,
AKT, and FOXO1 in mature B cells. Thus Dicer-, Drosha-, and
DGCR8-dependent miRNAs are essential for the downregulation
of BCR editing in peripheral B lymphocytes.
Complete Rescue of B Cell Development in the Absence
of miRNAs by combined Expression of Bcl2 and IgHEL
Transgenes
Bcl2-mediated rescue of B cell development in the absence of
Dicer, Drosha, or DGCR8 was only partial (Figures 3 and 7A).
We reasoned that expressing a EmBcl2 Tg together with a trans-
gene for a functional BCR that cannot be edited would lead to a
more complete rescue of miRNA-deficient B cells. We took
advantage of a Tg encoding a fully rearranged BCR specific for
hen egg lysozyme (HEL) (Goodnow et al., 1988). In the absenceCell Reports 17, 2271–2285, November 22, 2016 2281
of the pro-survival Bcl2 Tg, introduction of the IgHEL Tg by itself
is sufficient to mediate only partial rescue of B cell development
(5%–10% of littermate controls) upon ablation of RNAi (Fig-
ure 7A). In contrast to the limited rescue of B cell development
observed upon introduction of the individual transgenes (IgHEL
or Bcl2), we observed that Dicer1fl/fl Mb1-cre EmBcl2Tg IgHELTg
mice had a B cell compartment comparable in size to wild-type
animals (Figures 7A and 7B). These rescued B cells had surface
Ig levels comparable to Mb1-cre EmBcl2TgIgHELTg control
B lymphocytes (Figure 7B), but were indeed deficient in miRNAs
(Figure 7C).
DISCUSSION
Our analysis of B lymphocytes deficient in the enzymes neces-
sary for miRNA biogenesis revealed a critical role of miRNAs in
the coordination of early B cell development and specifically in
the maintenance of cell survival, proliferation, and regulation of
Ig editing. By comparing Dicer-, Drosha-, and DGCR8-deficient
B cells, we are able to confidently conclude that the observed
phenotypes are a consequence of miRNA loss and are not due
to loss of other classes of ncRNAs. We found that global loss
of miRNAs early in B cell development resulted in a block at
the pro-B to pre-B cell transition. This developmental defect
was due to increased apoptosis of pre-B cells associated with
high levels of the pro-apoptotic BH3 family member Bim in the
deleted cells. Moreover, upregulation of PTEN in the absence
of miRNAs led to reduced proliferation at the large pre-B cell
stage. Our previous analysis of Dicer-deleted B cells identified
the miR-1792 family as a promising candidate for the regula-
tion of both Bim and PTEN in developing B cells (Koralov et al.,
2008). In addition, the analysis ofmice deficient inmiR-1792 re-
vealed a similar reduction in pre-B cells numbers, increased
apoptosis of pro-B cells, and increased Bim levels in pro-B
and pre-B cells (Ventura et al., 2008). miR-148, which is highly
expressed in pro-B and pre-B cells, has recently been shown
to target both Bim and PTEN in immature B cells (Gonzalez-Mar-
tin et al., 2016) and might also regulate their expression in early
developing B cells. Our data suggest that miRNAs likely
contribute to the regulation of pre-B cell proliferation and survival
through the regulation of PI3K signaling via PTEN. These results
are consistent with data, suggesting that signaling through the
PI3K pathway, in particular downstream of the pre-BCR, is
important for early B cell development especially for the survival
and differentiation of pre-B cells (Werner et al., 2010). Further-
more, increased PTEN expression in the absence of miRNAs
may also contribute to the elevated level of the pro-apoptotic
protein Bim (Miletic et al., 2010).
As a result of the B cell developmental block, spleens of
Dicer1fl/fl Mb1-cre, Dgcr8fl/fl Mb1-cre, and Droshafl/fl Mb1-cre
mice were almost completely devoid of B cells. Overexpression
of the anti-apoptotic factor Bcl2 led to a partial rescue of B cells
in the spleen of Dicer1fl/fl Mb1-cre EmBcl2Tg, Dgcr8fl/fl Mb1-cre
EmBcl2Tg, and Droshafl/fl Mb1-cre EmBcl2Tg mice. The majority
of the rescued B cells expressed lower levels of surface IgM
than control Mb1-cre EmBcl2Tg expressing B cells. These Iglow
cells lacked any detectable surface or intracellular Ig light chain
and instead re-expressed l5 and VpreB. Iglow cells had evidence2282 Cell Reports 17, 2271–2285, November 22, 2016of increased light chain editing as determined by real-time PCR
and immuno-FISH experiments highlighting that the double
strand breaks at the Igk loci were occurring in the splenic Iglow
B cells. In addition, expression of the recombinase genes rag1/
2 was readily detectable in splenic Iglow cells even in mice where
bone marrow output was halted by administration of an anti-IL-
7Ra antibody. Furthermore, we could also detect expression of
Rag1 and Rag2 mRNA in mature B cells upon ablation of Dicer
from the spleen of Dicerfl/fl Mx1Cre mice by poly(I:C) injection.
Taken together with the presence of DSBs at Igk loci in Iglow
cells, the readily detectable expression of Rag1 and Rag2 indi-
cated ongoing IgL gene rearrangement in peripheral B lympho-
cytes in the absence of miRNAs. Light chain editing can be
associated with production or prevention of autoantibodies,
however, when we assayed humoral responses using a highly
sensitive validated multiplex assay, DGCR8-deficient adult
mice were devoid of detectable IgG autoantibodies to a range
of DNA/RNA-related autoantigens, while total serum IgG levels
were <15%of control mice (p < 0.008,MannWhitney, two-tailed)
(not shown).
Our data suggest that miRNAs are potent regulators of Rag1
and Rag2. The 30UTR of the Rag1 and Rag2 mRNAs harbors
very few putative target sites for miRNAs, and the few pre-
dicted sites that are revealed by Targetscan and PicTar algo-
rithms are complementary to miRNAs that are not thought to
be expressed in B lymphocytes. For this reason, Rag1 and
Rag2 mRNAs are not likely to be direct targets of miRNAs.
The PI3K pathway and the FOXO proteins, in particular
FOXO1, have been shown to regulate expression of Rag1
and Rag2 during light chain rearrangement in pre-B cells and
light chain editing in immature B cells lacking a functional light
chain, expressing an auto-reactive BCR or having insufficient
BCR ‘‘tonic’’ signal (Amin and Schlissel, 2008; Dengler et al.,
2008; Diamant et al., 2005; Herzog et al., 2008; Verkoczy
et al., 2007). Lymphocytes undergoing rearrangement display
dampened PI3K/AKT signaling, promoting elevated nuclear
levels of FOXO. We found that B cells lacking miRNAs had
increased levels of the PI3K pathway antagonist PTEN. Consis-
tently, phosphorylated and thus activated AKT levels were
decreased in miRNA-deficient B cells even as total AKT levels
were higher. This was associated with elevated levels of
FOXO1 protein in miRNA-deficient B cells. In addition to its
role in light chain rearrangement during B cell development,
the PI3K/AKT/FOXO pathway has been shown to be important
at later stages of B cell development—in particular in the regu-
lation of AID in activated B lymphocytes (Dengler et al., 2008),
the control of germinal center B cells (Sander et al., 2015;
Dominguez-Sola et al., 2015), and for the survival of mature
B cells in the context of ‘‘tonic’’ BCR signaling (Srinivasan
et al., 2009). Importantly, the use of PI3K and AKT inhibitors
on WT mature B cells in vitro allowed us to further demonstrate
that inhibition of the PI3K/AKT pathway in these cells induced
Rag1/2 expression. Our data suggest that in normal mature
splenic B cells, miRNAs regulate PTEN levels and possibly
FOXO1 (whose 30UTRs contain putative binding sites for
miRNAs expressed in B cells). PTEN is a known target of
several miRNAs, including miR-181, a miRNA highly expressed
in B cells (Chen et al., 2004), during NKT cell development
(Henao-Mejia et al., 2013), and miR-148 during immature B
cells (Gonzalez-Martin et al., 2016). The miR-1792 cluster
has also been shown to regulate PTEN in several cell types
(Xiao et al., 2008), in particular miR-19 might be regulating
PTEN at the immature B cell stage (Benhamou et al., 2016;
Lai et al., 2016). The present results indicate that in addition
to its pro-survival activity in mature B cells, the PI3K/AKT-
FOXO pathway is also critical for inhibiting aberrant Rag1/2
expression and light chain rearrangement in mature B cells.
Regulation of RAG expression in splenic B cells is absolutely
critical for preventing anomalous rearrangements that may
otherwise contribute to lymphomagenesis (Deriano et al., 2011;
Mills et al., 2003). However, additional levels of control, including
nuclear localization (Hewitt et al., 2009; Hu et al., 2015), prevent
fully rearranged Ig alleles from RAG-mediated recombination in
mature B lymphocytes. We did not observe aberrant IgH rear-
rangement in Dicer1fl/fl Mb1-cre EmBcl2Tg mice and did not
detect loss of IgL in B lymphocytes from Dicerfl/fl Mx1Cre mice
upon poly(I:C) injection. This could either be a reflection of Ig
loci inaccessibility in B cells where deletion of miRNAs only oc-
curs once the cells are fully mature or may be due to the limited
lifespan of Iglow cells in Dicerfl/fl Mx1Cre mice in the absence of
the Bcl2 Tg.
Expression of EmBcl2Tg together with the IgHEL transgene
allowed a complete rescue of B cell development in Dicer1fl/fl
Mb1-cre. We observed normal Ig expression on the surface of
the rescued B lymphocytes expressing the IgHEL transgene
that encodes both IgH and IgL chains of a functional BCR spe-
cific for hen egg lysozyme (HEL) and that is not amenable to re-
ceptor editing. Importantly, the IgHEL Tg by itself only partially
rescued B cell development in the absence of Dicer (Koralov
et al., 2008). The nearly complete rescue of RNAi-deficient B
cells by the combination of a pro-survival Bcl2 and pre-rear-
ranged Ig Tg suggests that miRNAs regulate both cellular sur-
vival and Ig light chain recombination during B cell development.
Our analysis of miRNA-deficient B cells suggests that by regu-
lating levels of PTEN, AKT, and FOXO1, miRNAs function in B
lymphocytes to regulate proliferation, survival, and to prevent
aberrant V(D)J rearrangement.EXPERIMENTAL PROCEDURES
Flow Cytometry and Cell Sorting
Single cell suspensions from spleen or bone marrow were stained for surface
or intracellular markers. Samples were analyzed on a LSR Fortessa cytometer
or sorted using a FACS Aria (BD Biosciences) or MoFlo (Beckman Coulter).
Data were analyzed with FlowJo software (Tree Star). A detailed description
is provided in the Supplemental Experimental Procedures.
miRNA and Gene Expression Analysis by Real-Time PCR
Total RNAwas extracted usingmirVanamiRNA Isolation Kit (Ambion). TaqMan
microRNA assays (Applied Biosystems) were used for reverse transcription
and detection of miRNA levels. The small RNA U6 was used for normalization.
Further isolation of longer RNAs was done by RNA cleanup using the RNeasy
Micro kit (QIAGEN). cDNA was synthesized from mRNA using SuperScript
VILO (Invitrogen). Real-time PCR was performed using a StepOne Plus PCR
system using SybrGreen master mix (Applied Biosystems). The expression
of target mRNA was calculated and normalized to the expression of the
housekeeping gene Hprt. The list of the primers used is described in the Sup-
plemental Experimental Procedures.Analysis of IgL Rearrangement by Real-Time PCR and Sequencing
Genomic DNA (gDNA) was isolated from sorted cells by proteinase K digestion
in Tris buffer at 56C 4 hr. gDNA was then used for real-time PCR analysis.
Levels were normalized to l5 genomic region. The list of the primers used is
described in the Supplemental Experimental Procedures. For sequencing of
Igk rearrangements, RNA was isolated from sorted cells and cDNA was pre-
pared. VkJk joints were amplified by PCR with high-fidelity Taq enzyme
(Roche) using a degenerate Vk primer, 50-agcttcagtggcagtgg(g/a)tc(a/t)gg(g/
a)ac-30, with a Ck primer, 50-cttccacttgacattgatgtc-30. PCR products were
subcloned into pgem T Easy Vector (Promega) and sequenced. Unique
sequences were analyzed using NCBI IgBlast program (http://www.ncbi.
nlm.nih.gov/igblast).
Statistical Analysis
Statistical analyses were performed using Prism 5.0 (GraphPad Software).
Data were analyzed with a Mann-Whitney test. A p value of <0.05 was consid-
ered significant. Immuno-FISH statistical analyses were performed using a
two-tail Fisher’s exact test: p values % 0.05 were taken to be significant.
P values displayed in the main figure were applied to combined data from
repeated experiments.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.11.006.
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Mb1-cre (Dicer KO), Dicer1fl/fl Mb1-cre EμBcl2Tg (Dicer KO Bcl2). Ctrl and Ctrl Bcl2 indicate the appropriate control mice 
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each genotype). (B) Loss of miRNAs in Droshafl/fl Mb1-cre EμBcl2Tg mice is shown by real-time PCR of a representative set 
of miRNAs on sorted B cells from the indicated mice. Taqman quantification of individual miRNAs was normalized against U6 
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all Igκ joints were calculated. (C) Real-time PCR of Vκ-RS, IRS-RS and Vλ-Jλ1 joints in the gDNA of the indicated cells sorted 
as in (A). Data is normalized to λ5 and levels in control cells set as 100% (mean ± SD). T cells from control mice are used as a 
negative control.
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 Figure S6, related to Figure 6: Rag1/2 are expressed in RNAi deficient B cells
(A) Representative graph of absolute number of Pre-B (B220+IgM-CD25+) from the BM of Dgcr8fl/fl Mb1-cre EμBcl2Tg 
(DGCR8 KO Bcl2) and Bcl2 expressing control mouse treated or not with anti-IL7Ra antibody. (B) Transcript levels of Rag1 
and Rag2 were assessed in Ighigh or Iglow splenic B cells deficient for DGCR8 (DGCR8 KO Bcl2) or in control B cells 
expressing Bcl2 Tg (Control Bcl2) treated or not with anti-IL-7R antibody. Data is normalized to hprt and represented as fold 
difference relative to Bcl2 Tg+ control pre-B cells. Values shown are mean ± SD. (C) FACS plots of B220 and AA4.1 (CD93) 
staining of the spleen Dicerfl/fl Mx1-Cre or Control Mx1-Cre mice one week after the last injection of poly(I:C). Number 
indicates the percentage of cells in the gate. (D) mRNA levels of Rag1 and Rag2 in Dicerfl/fl Mx1-Cre relative to control mice 
one week after poly(I:C) injection. (E) Levels of Foxo1 mRNA in the indicated cells. Data is normalized to hprt and represented 
as fold difference relative to Bcl2 Tg+ control pre-B cells. Values shown are mean ± SD. (F) Ratio of the median fluorescence 
intensity (MFI) of phospho Th 308 AKT to total AKT MFI (mean ± SD; n=6 mice).  
	  Table	  S1.	  Frequency	  of	  γ-­‐H2AX	  colocaliza:on	  with	  Igk	  locus	  	  (Related	  to	  Figure	  5C)
Igk
No	  associa:on	  
number	  	  	  	  	  %
γ-­‐H2AX	  associa:on
number	  	  	  	  	  %
sample	  size	  
(cells)
PreB	  	  	  	  Bcl2	  	  	  	  	  	  	  	  	  	  Exp1
	  	  	  	  	  	  	  	  	  	  Control	  	  	  	  	  	  	  Exp2	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Total
	  	  	  	  	  	  	  	  	  	  	  30	  	  	  	  	  	  	  	  	  	  56.6
	  	  	  	  	  	  	  	  	  	  	  65	  	  	  	  	  	  	  	  	  	  68.4
	  	  	  	  	  	  	  	  	  	  	  95	  	  	  	  	  	  	  	  	  	  64.2
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  23	  	  	  	  	  	  	  	  	  43.4
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  30	  	  	  	  	  	  	  	  	  31.6
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  53	  	  	  	  	  	  	  	  	  35.8
53
95
148
B	  cell	  	  	  Bcl2	  	  	  	  	  	  	  	  	  	  	  Exp1
	  	  	  	  	  	  	  	  	  	  Control	  	  	  	  	  	  	  Exp2	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Total
	  	  	  	  	  	  	  	  	  	  	  56	  	  	  	  	  	  	  	  	  	  	  93.3
	  	  	  	  	  	  	  	  	  	  	  94	  	  	  	  	  	  	  	  	  	  	  94
	  	  	  	  	  	  	  	  	  150	  	  	  	  	  	  	  	  	  	  93.75
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  	  	  	  6.7
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6	  	  	  	  	  	  	  	  	  	  	  	  	  	  6	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10	  	  	  	  	  	  	  	  	  	  	  6.25
60
100
160
B	  cell	  	  	  IgHigh	  	  	  	  	  	  Exp1
	  	  	  	  Dicer	  KO	  Bcl2	  	  Exp2	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Total
	  	  	  	  	  	  	  	  	  	  	  56	  	  	  	  	  	  	  	  	  	  	  94.9
	  	  	  	  	  	  	  	  	  	  103	  	  	  	  	  	  	  	  	  	  92.8
	  	  	  	  	  	  	  	  	  	  170	  	  	  	  	  	  	  	  	  	  93.5
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  	  	  	  5.1
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  8	  	  	  	  	  	  	  	  	  	  	  	  7.2
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	  	  	  	  	  	  	  	  	  	  	  6.5
	  	  	  	  	  	  	  	  	  	  	  	  	  	  59
	  	  	  	  	  	  	  	  	  	  	  	  	  111
	  	  	  	  	  	  	  	  	  	  	  	  	  170
B	  cell	  	  	  Iglow	  	  	  	  	  	  Exp1
	  	  	  	  Dicer	  KO	  Bcl2	  	  Exp2	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Total
	  	  	  	  	  	  	  	  	  	  	  51	  	  	  	  	  	  	  	  	  	  	  	  82.2
	  	  	  	  	  	  	  	  	  	  	  59	  	  	  	  	  	  	  	  	  	  	  	  83.1
	  	  	  	  	  	  	  	  	  	  110	  	  	  	  	  	  	  	  	  	  	  82.7
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	  	  	  	  	  	  	  	  	  17.7
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  12	  	  	  	  	  	  	  	  	  16.9
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  23	  	  	  	  	  	  	  	  	  	  17.3
	  	  	  	  	  	  	  	  	  	  	  	  	  	  62
	  	  	  	  	  	  	  	  	  	  	  	  	  	  71
	  	  	  	  	  	  	  	  	  	  	  	  	  133
	  	  	  	  	  	  	  	  	  	  	  	  Sta-s-cal	  analysis	  (Fisher	  exact	  test)	   P-­‐value	   Level
IgLow	  vs	  	  	  	  PreB	  Bcl2	  Control 0,00048 ***
Dicer	  KO	  Bcl2	  	  	  	  	  	  	  	  B	  cell Control 0,0047 **
IgHigh	  Dicer	  KO	  Bcl2 0,0053 **
Supplemental Experimental Procedures 
 
Animals 
Mice carrying floxed alleles for Dgcr8 (Wang et al., 2007) or Drosha (Chong et al., 2008) were bred with Mb1-cre 
animals (Hobeika et al., 2006) to generate Dgcr8fl/fl Mb1-cre, Droshafl/fl Mb1-cre and littermate controls. Dicer1fl/fl 
Mb1-cre mice were previously described (Koralov et al., 2008). Animals heterozygous for any of the three floxed 
alleles and positive for Mb1-cre did not display any detectable phenotype and were used as controls together with 
littermates that carried either the appropriate floxed alleles or the Mb1-cre allele in the absence of the floxed alleles. In 
some experiments, these mice were bred to Eµ-bcl-2 transgenic mice (Strasser et al., 1990), to IgHEL transgenic mice 
(Goodnow et al., 1988), or to mice expressing a human CD2 reporter knocked into the Rosa 26 locus downstream of a 
floxed stop cassette (R26hCD2stopfl/+)(Calado et al., 2012). Intraperitoneal injection of anti-IL7Ra antibody (A7R34; 
BioXcell) was performed every 3 days (0.5mg on day 1 then 0.25mg/injection) for two weeks. In some experiments, 
Ddicerfl/fl  (Murchison et al., 2005) were bred with Mx1-cre transgenic mice (Kuhn et al., 1995). In vivo deletion of 
Dicer was obtained upon intraperitoneal injection of poly(I:C) on days 1, 4 and 7 (0.4 mg/injection). Mice were 
analyzed 7-10 days after last injection. Mice were housed and maintained in specific pathogen-free conditions at NYU 
School of Medicine, Jackson Laboratory and the Technion Faculty of Medicine (Israel) in accordance with protocols 
approved by the NYU and Technion Institutional Animal Care and Usage Committee. Mice were used between 6–
10 weeks of age. 
 
Flow Cytometry and Cell Sorting 
For surface staining and cell sorting, single cell suspensions from spleen or bone marrow were stained 15 min on ice 
with antibodies specific to murine B220, CD19, c-kit, CD25, CD93 (AA4.1) (eBioscience), Igκ, Igλ (BD Biosciences) 
and IgM (µ chain specific) (Jackson ImmunoResearch). Dead cells were excluded by DAPI staining (Sigma). Annexin 
V staining was done according to manufacturer’s protocol (eBioscience). For intracellular staining, cells were surface 
stained and fixation/permeabilisation buffers from eBioscience were used. Antibodies for intracellular staining were 
IgM, Igκ, Igλ (as mentioned above), Bim (Epitomics); PTEN, FOXO1 (Cell Signaling) followed by FITC conjugated 
anti-rabbit antibody (Jackson ImmunoResearch). For cell proliferation, cells were fixed and stained in 2% 
paraformaldehyde (PFA) for the DNA intercalent DRAQ 5 (Biostatus) following surface staining. For phosphoflow 
staining, cells were surface strained then fixed in 2% PFA for 30 min at RT and permeablized with 90% methanol for 
30-60 min on ice. Cells were washed in PBS then stained for AKT, Phospho-AKT Thr308 and Phospho-AKT Ser473 
(Cell Signaling) followed by APC-conjugated anti-rabbit antibody (Jackson ImmunoResearch).  
 
Primers for gene expression Real-time PCR  
The following primers were used:  
Igll1 (lambda 5) forward 5’-CACATACTTTCCCCAAGCTC-3’;  
Igll1 (lambda 5) reverse 5’-GTGGGATGATCTGGAACAG-3’;  
VpreB forward 5’-CTATCTCACAGGTTGTGGC-3’;  
VpreB reverse 5’-GCCAATGTTATGGTCGTTG-3’; 
Drosha Forward 5’-GACGACGACAGCACCTGTT-3’as described in (Chong et al., 2008); 
Drosha Rev 5’-GATAAATGCTGTGGCGGATT-3’ as described in (Chong et al., 2008);  
DGCR8 Forw2 5’-CTAGAAGAAGGTCTCTGTG-3’;  
DGCR8 Rev2 5’-GGTATACAGGGACTCCAG-3’; 
Dicer Forw2 5’-CTGATGCTCATGAAGGCC-3’; 
Dicer Rev2 5’-CCCACTTCTCTGAGTTAC-3’;  
FoxO1 Forw1 5’-GTGAAGAGCGTGCCCTAC-3’ 
FoxO1 Rev1 5’-GGATTGAGCATCCACCAAG-3’ 
Cmu Membrane(M1) FW 5’-GAGCCTCTTCTACAGCACCACC-3’;   
Cmu Membrane(M2) REV 5’-GTCATACAGTCAGGTATCCCAGG-3’ 
Cmu4 Forw 5’-CTATACCTGTGTTGTAGGCCAC-3’; 
CmuSecreted_Rev 5’-CTAGCATGGTCAATAGCAGGTGC-3’; 
 RAG1 Fw: 5’-TTGCTATCTCTGTGGCATCG-3’ 
RAG1 Rv: 5’-AATTTCATCGGGTGCAGAAC-3’ 
RAG2 Fw: 5’-AGTGACTCTTCCCCAAGTGC-3’ 
RAG2 Rv: 5’-CTTCCTGCTTGTGGATGTGA-3’  
HPRT1-E1-F: 5'-GTCATGCCGACCCGCAGTC-3' 
HPRT1-E2-R: 5'-GTCCTGTCCATAATCAGTCCATGAGGAATAAAC-3' 
 
Primers for IgL rearrangement RT-PCR 
The following primers were used on genomic DNA 
IRS forward: 5’-GTAGCATCCCTTGCTCCGCGTGG-3’  
Vk forward: 5’-GCTTCAGTGGCAGTGGRTCWGGRAC-3’  
RS Rev: 5’-ACATGGAAGTTTTCCTGGGAGAATATG-3’  
Vlambda1 FW: 5’-ATCACAGGGGCACAGACTGAGG -3’ 
Jlambda: 15’-CTAGGACAGTCAGTTTGGTTCC-3’ 
Kappa Germline Forward: 5’-AGCTACCCACTGCTCTGTTC-3’ as described in (Zhou et al., 2010) 
Kappa Germline Reverse: 5’-CGTTTGATTTCCAGCTTGGT-3’ as described in (Zhou et al., 2010) 
Lambda 5 LOADING DNA Forward: 5’-TGCTGCTGTTGGGTCTAGTG-3’ 
Lambda 5 LOADING DNA Reverse: 5’-ACCTTCCCCAAAAAGCAAGT-3’  
 
PI3K Inhibitors 
Mature naïve B cells (B220+ CD19+ AA4.1-) were sorted from WT C57/B6 mice. Cells were cultured in RPMI with L-
glutamine (Corning) supplemented with 10% FBS (Hyclone), nonessential amino acids, 10 mM HEPES buffer, 1mM 
sodium pyruvate (Corning), penicillin-streptomycin (HyClone), and 0.1M 2-Mercaptoethanol (Sigma-Aldrich) at 37°C 
for the time indicated on the figure with DMSO, LY294002 (5µM or 10µM), PD98959 (10µM) (cell signaling), 
Wortmannin (10nM) or AKT inhibitor VIII (2mM) (Sigma-Aldrich). 
 
 
Immunoblotting 
BM and splenic B cells were FACS sorted and lysed in RIPA buffer containing 1 mM sodium orthovanadate and 5 mM 
sodiumfluoride and a protease inhibitor cocktail (Roche) for 15 minutes on ice. Proteins were resolved by SDS-Page 
and transferred to PVDF membranes (Millipore). Membranes were probed with antibodies specific to FOXO1. HRP-
goat anti rabbit antibody was used as a secondary antibody, followed by detection using enhanced chemiluminescence 
(ThermoFisher). Membranes were stripped and probed with anti-histone H3 antibody as loading control. All antibodies 
used for immunoblotting were from Cell signaling.  
 
DNA FISH with immunofluorescence (ImmunoFISH) 
Sorted pre-B and splenic B cells were adhered to poly-L-lysine coated coverslips, and fixed for 10 min at 22°C with 2% 
(wt/vol) PFA in PBS and permeabilized for 5 min with 0.4% (vol/vol) Triton in PBS. Samples were blocked for 30 min 
with 2.5% (wt/vol) BSA, 10% (vol/vol) normal goat serum and 0.1% (vol/vol) Tween-20 in PBS at 22°C. Samples were 
incubated for 1 h at 22°C with an antibody to phosphorylated serine 139 of H2AX (γH2AX; JBW301, Millipore) in 
blocking solution followed by staining with secondary goat anti-mouse IgG Alexa Fluor 488 (Life Technologies). Cells 
were post-fixed for 5 min at 22°C in 1% (wt/vol) PFA, re-permeabilized for 10 min at 0°C in 0.7% (vol/vol) Triton-X-
100 / 0.1 M HCl and incubated with RNaseA (0.1 mg/ml in PBS, 30 min at 37°C). Cells were then denatured for 30 min 
at 22°C with 1.9 M HCl and hybridized overnight at 37°C with denatured DNA probes. Cells were mounted in Prolong 
Gold (Life Technologies) containing 1.5µg/ml DAPI (Sigma). DNA probes were prepared by labeling BAC clones 
RPCI-24-387E13 (IgkC), RPCI-23-101G13 (IgkV) by nick translation with ChromaTide Alexa Fluor 488-5 or 594-5-
dUTP (Life Technologies). 
 
Confocal microscopy and ImmunoFISH analysis  
Cells were imaged by confocal microscopy on a Leica SP5 AOBS system (Acousto-Optical Beam Splitter). Optical 
sections separated by 0.3 µm were collected and only cells with signals from both alleles were analyzed using Image J 
software (NIH). Alleles were defined as colocalized with γH2AX if the signals directly overlapped (at least one pixel of 
colocalization).  
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